SOURCE: TheSUBWAY.com

January 30, 2008 08:47 ET

Early Alert Small Cap Trade Opportunity for Wednesday, January 30, 2008: HNSO New Program Already Generating Revenue!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.

WESTON, FL--(Marketwire - January 30, 2008) - TheSUBWAY.com announces the following stocks to its Action List: Healthnostics, Inc. (PINKSHEETS: HNSO), Zoran Corporation (NASDAQ: ZRAN), Altera Corporation (NASDAQ: ALTR), Clearwire Corporation (NASDAQ: CLWR).

Visit TheSUBWAY's Small Cap Investor Forum Here: http://www.thesubway.com/small-cap-forum/ to discuss our daily stock picks throughout the trading day!

Healthnostics, Inc. (PINKSHEETS: HNSO), a medical and biotechnology analytics information and technology company, today announced that the MedBioWorld medical and biotechnology journal database has been expanded by 26% to over 16,000 listings, including the recent addition of the Journal Citation Reports™ ranking of the world's leading journals. In conjunction with this expansion, MedBioWorld has initiated a new affiliate program that has attracted partners who have already begun to generate revenue for Healthnostics.

Other stocks highlighted include Zoran Corporation (NASDAQ: ZRAN): Hot Stocks List, down 15% on 7 million shares, Altera Corporation (NASDAQ: ALTR): Hot Stocks List, down 2% on 8 million shares, Clearwire Corporation (NASDAQ: CLWR): Hot Stocks List, up 23% on 5 million shares.

TheSUBWAY.com's Daily Stock Updates:

TheSUBWAY.com, a leader in corporate communications and finance, highlights stocks that are in the news, have traded high volume, or experienced a large change in price in recent sessions. The aforementioned commentary is not meant to be indicative of a "long term" view of any of the companies listed. For more go to http://www.thesubway.com.

All material herein was prepared by CRG Partners, Inc. (CRGP) based upon information believed to be reliable. The information contained herein is not guaranteed by CRGP to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. CRGP is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.thesubway.com or mentioned herein. CRGP has been compensated by third party shareholders with shares or with cash from the company on behalf of one or more of the companies mentioned in this opinion. CRGP has been compensated eight hundred fifty thousand shares for HNSO. CRGP was compensated by StockPromoters.com Consultants LLC who received ten million shares of HNSO for their services. The owner of StockPromoters.com Consultants LLC is also the owner of Capital Research Group Inc. and TheSUBWAY.com Inc. For more information on this visit: http://www.StockPromoters.com. CRGP intends to sell its shares. CRGP has sold approximately zero HNSO shares to date. CRGP may sell its shares for less than the target price given in this opinion. In addition to any compensation mentioned above, additional compensation can be equal to ten percent of any newly issued or registered securities of the profiled companies. CRGP and its web site operates under a license from Capital Research Group, Inc., TheSUBWAY.com Inc. and One Source Solutions Inc. (Licensors) and CRGP is not the agent of any of the Licensors and CRGP is solely responsible for all statements made herein. CRGP's Licensors, affiliates, officers, directors and employees own shares and intend to buy and sell additional shares of the company mentioned herein and may profit in the event those shares rise in value. CRGP will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

Contact Information